Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

NCT04451200 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia
Mielodysplasic Syndrome
Myeloproliferative Neoplasm

Interventions

DRUG: Busulfan Injection

Sponsor

Institut Paoli-Calmettes